BioMarin Pharmaceutical, Inc. (BMRN)
55.91
+0.71
(+1.29%)
USD |
NASDAQ |
Jan 14, 11:47
BioMarin Pharmaceutical Price: 55.91 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.34 |
| Gilead Sciences, Inc. | 122.84 |
| Merck & Co., Inc. | 108.84 |
| AbbVie, Inc. | 219.53 |
| Bristol Myers Squibb Co. | 56.42 |
Price Related Metrics
| PE Ratio | 20.95 |
| PS Ratio | 3.544 |
| PEG Ratio | 0.3451 |
| Price to Book Value | 1.773 |
| Price to Free Cash Flow | 13.24 |
| Earnings Yield | 4.77% |
| Market Cap | 10.74B |
| PEGY Ratio | 0.3451 |
| Operating PE Ratio | 12.78 |
| Normalized PE Ratio | 15.67 |